PABYX
Price
$16.65
Change
-$0.10 (-0.60%)
Updated
Aug 1 closing price
Net Assets
2.23B
RLBCX
Price
$36.51
Change
-$0.26 (-0.71%)
Updated
Aug 1 closing price
Net Assets
252.98B
Interact to see
Advertisement

PABYX vs RLBCX

Header iconPABYX vs RLBCX Comparison
Open Charts PABYX vs RLBCXBanner chart's image
Putnam Dynamic Asset Allocation Bal Y
Price$16.65
Change-$0.10 (-0.60%)
VolumeN/A
Net Assets2.23B
American Funds American Balanced R3
Price$36.51
Change-$0.26 (-0.71%)
VolumeN/A
Net Assets252.98B
PABYX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PABYX vs. RLBCX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABYX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. PABYX (2.23B). PABYX pays higher dividends than RLBCX: PABYX (3.17) vs RLBCX (1.56). PABYX was incepted earlier than RLBCX: PABYX (31 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PABYX (0.68). PABYX is a more actively managed with annual turnover of: 222.00 vs. RLBCX (44.00). PABYX has a lower initial minimum investment than RLBCX: PABYX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 7.14 vs. PABYX (2.92). RLBCX return over 5 years is better than : 35.49 vs. PABYX (20.93).
PABYXRLBCXPABYX / RLBCX
Total Expense Ratio0.680.8976%
Annual Report Gross Expense Ratio0.680.8976%
Fund Existence31 years23 years-
Gain YTD7.3457.53497%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.23B253B1%
Annual Yield % from dividends3.171.56204%
Returns for 1 year2.927.1441%
Returns for 3 years22.8329.8177%
Returns for 5 years20.9335.4959%
Returns for 10 years34.6359.4958%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LII605.87-3.13
-0.51%
Lennox International
OUT17.22-0.31
-1.77%
OUTFRONT Media Inc
MCRB13.99-0.27
-1.89%
Seres Therapeutics Inc
APRE1.66-0.04
-2.35%
Aprea Therapeutics
TIPT20.26-0.52
-2.50%
Tiptree